Future Cannabis Strategy Conference Europe 2021

Biography:

Paul has been Head of the Radiological, GM, Novel Foods and Feed Additives Team since Jan 2019. He has been with the FSA since its formation in 2000, having previously been in the Ministry of Agriculture, Fisheries and Food (MAFF). He has led on several policy areas of food safety  including leading on food defence then Allergy & Intolerance team

Session Details: FSA on CBD: The Novel Food Authorisation Process 23-03-2021, 9:00 am View In Agenda

Biography:

Jonathan Sherman is a partner at Cassels Brock & Blackwell LLP and the Co-Chair of the Cannabis Law Group. Jonathan is routinely retained to act on behalf of a wide variety of cannabis industry participants, including: licensed and pre-licensed cultivators, processors and retailers in Canada, the US and other international jurisdictions; pharmaceutical, beverage and consumer goods companies seeking opportunities in the emerging global cannabis sector; and other ancillary businesses.

With corporate clients ranging from start-ups to multibillion-dollar businesses, Jonathan’s practice focuses on mergers and acquisitions (public and private acquisitions, business combinations, joint ventures, go-public transactions and strategic collaborations) and corporate finance transactions (public offerings, venture capital, private equity offerings and debt financing transactions). Jonathan has also been involved in other domestic, cross-border transactions for cannabis industry participants, including: various private equity investments for emerging companies; reverse takeover transactions; joint ventures; and acquisitions and investments in companies both in Canada and abroad (the US, Italy, Denmark, Poland, Greece, Czech Republic, Colombia, Jamaica, Brazil, Chile, Australia and Lesotho).

Whether strategically guiding clients through M&A, or helping emerging start-ups secure investments, Jonathan has been a trusted advisor on many of the largest transactions completed to-date in the nascent cannabis industry. He advised Canopy Growth on: their listing as the first-ever cannabis company on the New York Stock Exchange; over $1 billion of M&A transactions; the $600 million offering of senior convertible unsecured notes – the largest convertible debt financing to-date completed by a company listed on a Canadian stock exchange; the joint venture, licensing and development of the largest cannabis production facility in the world; and various supply and processing arrangements involving (among others): MediPharm Labs, 48North, Radicle Cannabis, James E. Wagner Cultivation, Neptune Technologies & Bioresources, and Centric Health.

Session Details: International Cannabis Markets: Were Initial Predications Too High? 23-03-2021, 3:45 pm View In Agenda

Biography:

Session Details: International Cannabis Markets: Were Initial Predications Too High? 23-03-2021, 3:45 pm View In Agenda

Biography:

Session Details: A Vaping Hole – CBD in the Regulatory & Public Affairs Arena 23-03-2021, 4:45 pm View In Agenda

Biography:

Session Details: The Evolution of Cannabis Packaging: From Canada, to the United States, to Europe 23-03-2021, 4:15 pm View In Agenda

Biography: Dr. Guillermo Moreno-Sanz has authored more than 30 scientific articles and 3 patents describing the role of the endocannabinoid system in pain perception. Graduated in Biochemistry and Organic Chemistry from the University of Zaragoza, he obtained his PhD in Neuroscience from the Complutense University of Madrid, in Spain. He gained extensive international experience with long-term fellowships in the Netherlands, Italy, and the United States, developing most of his academic career at the University of California, Irvine, where he discovered a new class of cannabinoid analgesic, currently under clinical development. In 2017, he acted as a consultant to the National Academies of Sciences of the United States in the preparation of the report "The health effects of cannabis and cannabinoids" and founded his consulting firm, Abagune Research, to offer scientific advice and R&D solutions to the international cannabis industry. In 2020 he assumed the scientific and medical direction of Khiron Life Sciences in Europe.

Session Details: Magnificent Waves for CBD in the Medical Market 24-03-2021, 9:30 am View In Agenda

Biography: Franziska is an accomplished business executive and legal expert (zugelassene Rechtsanwältin) who brings extensive experience working within Europe’s emerging cannabis industry. Franziska joined worldwide largest corporate law firm Dentons, where she was involved in high-profile deals in the cannabis and life sciences sector across multiple jurisdictions. Prior to joining Khiron Life Sciences in September 2019, Franziska later served as Director of Legal, Europe for Canopy Growth Corporation.    

Session Details: Q&A Session: Mapping the CBD Legal Landscape 2021 23-03-2021, 11:00 am View In Agenda

Biography:

Session Details: How Can NPD products be approached in Europe with so many different regulatory situations? 24-03-2021, 11:30 am View In Agenda

Biography: West London-based Jonathan Stefanni-Machado is CEO & Co-Founder of Treed. He spent the last five years managing businesses in the retail, health & wellness sectors before co-founding Treed. As a business leader, and also a writer in the cannabis space, with a background in English Literature & American History, Jonathan is now on a journey to re-write attitudes towards health, reshape social attitudes towards hemp, and empower those who have been misrepresented in recent years.v

Session Details: Using History to Cultivate our Futures: Understanding why Diversity & Inclusion are Essential in the Cannabis Industry 24-03-2021, 3:35 pm View In Agenda

Biography:

Session Details: The Beauty of Flying High-end with CBD: Accolades and Awards 23-03-2021, 1:50 pm PANEL: Taking the World by Storm: Opportunity in Unexplored Continents 24-03-2021, 1:10 pm View In Agenda

Biography:

Session Details: The ABCs of CBD Trade: Entering International Markets 23-03-2021, 10:00 am View In Agenda

Biography: Catherine is Vice President of the European Industrial Hemp Association. EIHA was formed 19 years ago and is the only pan-European membership organization in the industrial hemp sector. Our secretariat offices in Brussels and the UK representation protect and support our membership of 200+, primarily farmers, processors and manufacturers; representing the entire chain from seed to shelf. Our primary objective is to monitor EU/UK hemp related policies and to provide the decision makers with accurate and reliable information across different spheres of competencies. Currently we monitor the following policies: CAP reform, Hemp extracts/Novel Food regulation, THC limits in feed and food, Life Cycle Assessment of hemp materials, CO2 impacts, environmental concerns and cosmetics. In addition, EIHA formed the largest novel food consortium and pending a successful outcome, EIHA consortium member company's products will be allowed to be marketed in the UK/EU with an exclusivity on the study that will last 5 years.

Session Details: The EIHA Novel Food Consortium 24-03-2021, 8:25 am View In Agenda

Biography:

Session Details: Consumer format preferences & dose-form migrations – zooming in on CBD users 24-03-2021, 3:05 pm View In Agenda

Biography:

Session Details: The Green Rush: Breaking through the CBD Stock Market 24-03-2021, 2:35 pm View In Agenda

Biography: As a previous drinks industry executive, Craig developed the strategy, built the structure, & implemented the RTM & brand plans for Pernod Ricard's charge into Africa. Before that he was Strategy Director for Absolut, Malibu and Kahlua, driving the strategic plan & brand development strategy. Since leaving the drinks world in 2015 he has been involved in business process outsourcing to Africa, setting up a values-based, people management web-platform, and consulting. He also presents on futurology; how our lives are going to change dramatically over the coming decades. Early 2017, Craig (South African) and his wife Maria (Swedish) discovered a magical valley, home to many intriguing botanicals, in the Cederberg mountains, just north of Cape Town. The valley, which they now co-own, inspired them to distil rare Cape & classic gin botanicals, and then blend with pristine Swedish water. The result is CEDER'S, a distilled non-alcoholic alt-gin, your Everyday Escape. Craig also launched CELTIC SOUL in July 2019, a distilled non-alcoholic dark spirit, and has a few more brands in the pipeline, including a non-alcoholic rum and a CBD Botanical Spirit. Watch this space.

Session Details: Packing a Punch with CBD in No and Low 24-03-2021, 10:00 am PANEL: Taking the World by Storm: Opportunity in Unexplored Continents 24-03-2021, 1:10 pm View In Agenda

Biography:

Session Details: PANEL: Taking the World by Storm: Opportunity in Unexplored Continents 24-03-2021, 1:10 pm View In Agenda

Biography:

Session Details: Q&A Session: Mapping the CBD Legal Landscape 2021 23-03-2021, 11:00 am Looking into the Future: What's in store for Medical Cannabis across Europe and the UK? 24-03-2021, 12:00 pm View In Agenda

Biography:

Session Details: Q&A Session: Mapping the CBD Legal Landscape 2021 23-03-2021, 11:00 am A Question of Medicine: Redefining the Medicine Pathway and granting Patient Access 23-03-2021, 12:10 pm View In Agenda

Biography: Tom has over 10 years experience in FMCG across a breadth of categories. Most recently though, he and a team of like-minded entrepreneurs, product scientists and brand builders grouped together to form OTO International Ltd. OTO, which translates as 'sound' in Japanese, aims to help people discover the amazing power of CBD through thoughtful and effective products that easily and enjoyably fit into our daily lives. Tom has been spear-heading OTO's growth into new territories and is looking at continued ways to ensure OTO remains the thought, brand and market leader in this growing space.

Session Details: PANEL: Taking the World by Storm: Opportunity in Unexplored Continents 24-03-2021, 1:10 pm Amplify the Silence for Better Beauty Sleep 24-03-2021, 4:05 pm View In Agenda

Biography:

Session Details: View In Agenda

Biography: David is a Chartered Engineer who has worked internationally in large corporations and technology start-ups commercialising innovative technology prior to embarking on his consulting career. His experience encompasses both reduced-risk nicotine and cannabinoid products, spanning the full development cycle of user research, prototype development and the transition to production. Through his work supporting CDP’s clients, he has developed a deep understanding of the technological, commercial and regulatory issues impacting these emerging sectors.

Session Details: Routes to Success in the Therapeutic Cannabinoid Market 24-03-2021, 4:35 pm View In Agenda

Biography: Robert brings significant experience onboard in expanding businesses geographically while promoting diversity and inclusion within. He gathered his experience in healthcare, telecommunications, IT and system integration. He worked at companies such as T-Mobile, T-Systems and Philips. As the Global Sales Transformation Leader, Robert successfully designed new business models and drove transformation. Based on his extensive experience, he is a firm believer in teamwork and he is constantly seeking superb team players for RotaChrom. The key to his success is building organizations with strong cultures of commitment, innovation, and drive to overcome challenges while maintaining a positive work environment. He loves spreading great business practices and helping startup ideas to grow and later to scale.

Session Details: Q&A Session: Mapping the CBD Legal Landscape 2021 23-03-2021, 11:00 am Sharing results and conclusions from our Customers and Partners from around the world. Bringing you the essence of how the best are differentiating themselves from the others. We will look at: 23-03-2021, 11:30 am View In Agenda

Biography: Marica Barbieri studied at the University of Pavia, obtaining a degree in Chemistry in 2003 and a Bioinorganic Chemistry Ph.D. in 2006. She worked for two years in an analytical laboratory dealing, as Studies Director, with the development and validation of analytical methods. For 10 years she has held the role of Product Specialist of Liquid Chromatography and Mass Spectrometry in Agilent Technologies Italy. During these years she have gained technical and application experience on the main LC and LCMS hardware and software platforms, participating in the introduction on the market of new products and technologies.

Session Details: Reliable and Ready-to-Run Cannabis Testing 23-03-2021, 9:30 am Cannabis Testing Insights from Agilent 24-03-2021, 10:30 am View In Agenda

Biography:

Session Details: Cannabis 3.0: The Dawn of Cannabis as a True Consumer Packaged Good 23-03-2021, 3:05 pm View In Agenda

Biography: Mira Doig, Ph.D., Technical Director at ABS Laboratories, Ltd. Mira has over 30 years of experience performing regulated bioanalysis of drugs, metabolites, and biomarkers using GC-MS & LC-MS/MS, and has supported multiple drug development programs from discovery to MAA/NDA submission. In 1997 she established ABS Laboratories as a GLP/GCP accredited bioanalytical contract research organization, which was acquired by ACM Global Labs in 2018. Today, she continues to oversee ACM’s bioanalysis laboratory services and maintains technical and operational excellence.

Session Details: Bioanalytical Experience and How it Can Support CBD Vaping Products 24-03-2021, 12:40 pm View In Agenda

Biography:

Session Details: A Question of Chemistry: Developing a Safe Delivery Vehicle for CBD/THC Vape Products 23-03-2021, 2:35 pm View In Agenda

Biography: ,

Session Details: Unlocking the potential of cannabis 23-03-2021, 1:10 pm View In Agenda